I am confident the management will not screw up handling the news release next week. But they need to know that they make sure of using the clearest possible message. Otherwise they will unintentionally produce negative impression in the market when the result is actually good/outstanding. With all data known about the trial up to now, I'm expecting equal or improve number on PFS, and also for OS. If they show significant better number on OS, then it's a fantastic news for the company and the investors. I'm confident in CEO, and I hope he delivers the news release well next week.
the shorts will attack ferociously IF PFS number to be reported next week is a little less (but not significantly reduced) than the 2nd trial pfs result. even though it still demonstrate significant advantage over ifos+dox. I just hope that when mgmt releases the news, that they use the most positive tone to prevent any negative reactions.